ABBOTT Established Pharmaceuticals

At ABBOTT Established Pharmaceuticals, we recognize the critical role that independent research plays in advancing medical science and improving patient care.

IGate is the Abbott Established Pharmaceutical Division’s official submission portal for Investigator Initiated Studies (IIS). iGATE is designed to streamline how you submit your request, making it easy to track and manage your institutional data and documentation.

Investigators who wish to explore innovative, evidence-generating studies aligned with our therapeutic areas should submit the study requests through IGate.

Purpose of lGate (IIS Portal):

• To provide a transparent and structured process for submitting IIS proposals
• To foster scientific collaboration with external researchers and institutions
• To ensure compliance with applicable local laws, rules, guidelines, and regulations
• To facilitate the review and potential support of high-quality, investigator-led research

ABBOTT provides support for Investigator-Initiated Studies in accordance with a written agreement. All third-party sponsors are required to comply with relevant legal and regulatory standards. Through this portal, we aim to empower investigators to pursue meaningful research that contributes to better health outcomes globally.